118 filings
Page 4 of 6
8-K
xsp8 yt3gqqrmtz32gu
15 Jul 21
Other Events
5:06pm
8-K
16e3uyux9l3ig 2i
28 Jun 21
Regulation FD Disclosure
4:15pm
8-K
2179dpu 5oidbh6d
11 Jun 21
Other Events
6:21am
8-K
ypf1x tv5axggs7
7 Jun 21
Submission of Matters to a Vote of Security Holders
4:34pm
8-K
rgtcg
6 May 21
X4 Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
8:13am
8-K
fzk2nnhcg
9 Apr 21
Regulation FD Disclosure
4:09pm
8-K
yv6c9hps1a3jn37p45
19 Mar 21
X4 Pharmaceuticals Announces $55.0 Million At-the-Market Private Placement Financing
9:05am
8-K
6fyt8xugud3x9kmn
4 Mar 21
X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
8:23am
8-K
8qxdbdli0m q4rs
8 Jan 21
Regulation FD Disclosure
4:17pm
8-K
no9we
23 Dec 20
Entry into a Material Definitive Agreement
5:01pm
8-K
byi re2pvc93
5 Nov 20
X4 Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
8:13am
8-K
uflb4ydmkd2euxoh6oh
16 Oct 20
Entry into a Material Definitive Agreement
4:16pm
8-K
3l9hkus uo0zd
7 Oct 20
Other Events
5:11pm
8-K
oy73qkb yhw9kv
1 Oct 20
X4 Pharmaceuticals Expands Board of Directors Through Appointment of Biopharmaceutical Industry Veteran Alison Lawton
8:31am
8-K
mgc9hq9aud
11 Sep 20
Other Events
4:26pm
8-K
1upj3o
30 Jul 20
X4 Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
8:11am
8-K
ejgw6yhlxr 7xn
11 Jun 20
Material Modifications to Rights of Security Holders
4:12pm
8-K
wpvdgza5b2wq e0fw
7 May 20
X4 Pharmaceuticals Provides Corporate Update, Including Expected Impact of COVID-19, and Reports First Quarter 2020 Financial Results
8:04am
8-K
s6v9q4y1a
20 Mar 20
Departure of Directors or Certain Officers
4:06pm
8-K
dbi40sch f2
17 Mar 20
Entry into a Material Definitive Agreement
4:52pm